CN113083176B - A kind of preparation method and application of hollow proanthocyanidin wall material microcapsules - Google Patents
A kind of preparation method and application of hollow proanthocyanidin wall material microcapsules Download PDFInfo
- Publication number
- CN113083176B CN113083176B CN202110352188.6A CN202110352188A CN113083176B CN 113083176 B CN113083176 B CN 113083176B CN 202110352188 A CN202110352188 A CN 202110352188A CN 113083176 B CN113083176 B CN 113083176B
- Authority
- CN
- China
- Prior art keywords
- proanthocyanidin
- hollow
- wall material
- zif
- microcapsules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 title claims abstract description 53
- 229920001991 Proanthocyanidin Polymers 0.000 title claims abstract description 53
- 239000003094 microcapsule Substances 0.000 title claims abstract description 51
- 239000000463 material Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 229920002770 condensed tannin Polymers 0.000 claims abstract description 42
- 239000002245 particle Substances 0.000 claims abstract description 42
- 239000000341 volatile oil Substances 0.000 claims abstract description 23
- 239000003814 drug Substances 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims abstract description 7
- 239000013154 zeolitic imidazolate framework-8 Substances 0.000 claims abstract 11
- MFLKDEMTKSVIBK-UHFFFAOYSA-N zinc;2-methylimidazol-3-ide Chemical compound [Zn+2].CC1=NC=C[N-]1.CC1=NC=C[N-]1 MFLKDEMTKSVIBK-UHFFFAOYSA-N 0.000 claims abstract 11
- 239000007864 aqueous solution Substances 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 22
- 239000006185 dispersion Substances 0.000 claims description 18
- 238000005406 washing Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 claims description 12
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 238000005530 etching Methods 0.000 claims description 9
- 238000005119 centrifugation Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 claims description 7
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- XIOUDVJTOYVRTB-UHFFFAOYSA-N 1-(1-adamantyl)-3-aminothiourea Chemical compound C1C(C2)CC3CC2CC1(NC(=S)NN)C3 XIOUDVJTOYVRTB-UHFFFAOYSA-N 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- PMRYVIKBURPHAH-UHFFFAOYSA-N methimazole Chemical compound CN1C=CNC1=S PMRYVIKBURPHAH-UHFFFAOYSA-N 0.000 claims 1
- 229960002178 thiamazole Drugs 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 238000011068 loading method Methods 0.000 abstract description 6
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- 230000001093 anti-cancer Effects 0.000 abstract description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 239000002798 polar solvent Substances 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 description 16
- 239000002244 precipitate Substances 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000011162 core material Substances 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 241000218691 Cupressaceae Species 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- -1 zinc nitrate hexahydrate 2-methylimidazole Chemical compound 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920002414 procyanidin Polymers 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000002411 thermogravimetry Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002154 agricultural waste Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229930182497 flavan-3-ol Natural products 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000010909 process residue Substances 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/025—Applications of microcapsules not provided for in other subclasses
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种空心原花青素壁材微胶囊的制备方法及其应用。原花青素是一种具有良好抗菌、抗氧化以及抗癌细胞活性的植物多酚类化合物。原花青素广泛存在于颜色较深的水果植物树皮当中。但原花青素没有固定的空间立体形态且易溶于极性溶剂中,因而普通的原花青素在包埋应用中受到限制。本发明的空心原花青素微胶囊是由ZIF‑8作为牺牲模板,并以原花青素作为刻蚀剂对ZIF‑8进行刻蚀,最终获得了粒径在200纳米左右的空心原花青素壁材微胶囊。以空心原花青素壁材微胶囊对柏木精油进行包埋,最终获得了约26%装载量的柏木精油缓释微胶囊。本发明成功的构建了一种以原花青素为壁材的空心微胶囊,可用于易氧化变质的药物或精油的包埋领域。
The invention discloses a preparation method and application of hollow proanthocyanidin wall material microcapsules. Proanthocyanidin is a plant polyphenolic compound with good antibacterial, antioxidant and anticancer activities. Proanthocyanidins are widely found in the bark of darker fruit plants. However, proanthocyanidins have no fixed three-dimensional shape and are easily soluble in polar solvents, so ordinary proanthocyanidins are limited in embedding applications. The hollow proanthocyanidin microcapsules of the present invention use ZIF-8 as a sacrificial template, and use proanthocyanidin as an etchant to etch ZIF-8, and finally obtain hollow proanthocyanidin wall material microcapsules with a particle size of about 200 nanometers. The cedarwood essential oil was embedded in the hollow proanthocyanidin wall material microcapsules, and finally the cedarwood essential oil slow-release microcapsules with a loading capacity of about 26% were obtained. The invention successfully constructs a hollow microcapsule with proanthocyanidin as the wall material, which can be used in the field of embedding of oxidatively degenerated medicines or essential oils.
Description
技术领域technical field
本发明属于材料制备领域,涉及一种空心原花青素壁材微胶囊的制备方法及其应用,具体涉及一种以原花青素为壁材的空心微胶囊的制备方法及其制得的空心微胶囊在药物或精油包埋领域的应用。The invention belongs to the field of material preparation, and relates to a method for preparing hollow proanthocyanidin wall material microcapsules and its application, in particular to a method for preparing hollow microcapsules with proanthocyanidin as wall material and the prepared hollow microcapsules used in medicine or Applications in the field of essential oil embedding.
背景技术Background technique
原花青素是一种广泛存在于植物体表及体内的是具有各种药理特性的缩合单宁。例如原花青素拥有良好的抗氧化性、抗菌特性、抗癌细胞活性等性质。原花青素是类黄酮生物合成途径的终产物,由单体黄烷-3-醇构成的低聚物或多聚物,在农业废料和食品加工废料中大量存在。Proanthocyanidins are condensed tannins with various pharmacological properties that widely exist on the surface and body of plants. For example, proanthocyanidins have good antioxidant properties, antibacterial properties, anti-cancer properties and other properties. Proanthocyanidins are the final products of flavonoid biosynthetic pathways, oligomers or polymers composed of monomeric flavan-3-ols, and are abundant in agricultural wastes and food processing wastes.
目前原花青素的应用研究还局限于原花青素本身的上述性质,业内广泛以原花青素作为微胶囊芯材进行包埋,以突出原花青素作为芯材的效用。张婉萍等人以壳聚糖包埋原花青素应用在化妆品领域;王芳等人以麦芽糊精和阿拉伯胶包埋低聚原花青素应用于保健食品领域;谭明乾等人以明胶-海藻酸钠包埋原花青素亦有望应用于食品领域。综上,目前的原花青素都是作为微胶囊芯材进行包埋,旨在不同领域发挥出原花青素部分功能。然而,目前并没有将原花青素开发为一种微胶囊壁材的案例。本发明通过牺牲模板的方法来获得空心原花青素微胶囊,并利用原花青素作为微胶囊壁材,因其自身的抗菌抗氧化性质,在芯材的保护领域具有十分广阔的应用前景,有望应用于医药开发、装载精油等领域。此外,原花青素作为一种颜色会随着环境PH值变化而变化的天然多酚,在酸性条件下呈现出红色,在碱性条件下呈现出蓝色。而食物腐败后其PH值偏向于酸性,因而以原花青素作为活性食品包装,对食物是否腐败进行直观判断亦拥有较好的前景。At present, the research on the application of proanthocyanidins is still limited to the above-mentioned properties of proanthocyanidins themselves. In the industry, proanthocyanidins are widely used as microcapsule core materials for embedding to highlight the effectiveness of proanthocyanidins as core materials. People such as Zhang Wanping used chitosan to embed proanthocyanidins in the field of cosmetics; people such as Wang Fang used maltodextrin and gum arabic to embed oligomeric proanthocyanidins in the field of health food; people such as Tan Mingqian used gelatin-sodium alginate to embed procyanidins. It is expected to be applied in the food field. To sum up, the current proanthocyanidins are all embedded as microcapsule core materials, aiming to exert some functions of proanthocyanidins in different fields. However, there is currently no case of developing proanthocyanidins as a microcapsule wall material. The present invention obtains hollow proanthocyanidin microcapsules by sacrificing the template, and uses proanthocyanidin as the microcapsule wall material. Because of its own antibacterial and anti-oxidation properties, it has a very broad application prospect in the field of core material protection and is expected to be applied to medicine development. , loading essential oils and other fields. In addition, proanthocyanidins, as a natural polyphenol whose color changes with the pH value of the environment, appear red under acidic conditions and blue under alkaline conditions. After the food is spoiled, its PH value tends to be acidic, so using proanthocyanidins as active food packaging also has a good prospect for visually judging whether the food is spoiled.
发明内容Contents of the invention
本发明的目的在于提供一种空心原花青素壁材微胶囊的制备方法及其应用;该方法在常温水溶液中即可完成。为得到不同粒径大小的空心原花青素壁材微胶囊,可通过控制牺牲模板ZIF-8的粒径大小从而间接控制空心原花青素壁材微胶囊的大小。The object of the present invention is to provide a preparation method and application of hollow proanthocyanidin wall material microcapsules; the method can be completed in normal temperature aqueous solution. In order to obtain hollow proanthocyanidin wall material microcapsules with different particle sizes, the size of the hollow proanthocyanidin wall material microcapsules can be indirectly controlled by controlling the particle size of the sacrificial template ZIF-8.
为达到上述目的,本发明提供了以下技术方案:To achieve the above object, the present invention provides the following technical solutions:
第一方面,本发明涉及一种空心原花青素壁材微胶囊的制备方法,以沸石咪唑骨架-8(ZIF-8)为硬模板,以原花青素为刻蚀剂,刻蚀ZIF-8后形成以原花青素为壁材的空心微胶囊。In the first aspect, the present invention relates to a method for preparing hollow proanthocyanidin wall material microcapsules, using zeolite imidazole framework-8 (ZIF-8) as a hard template, using procyanidin as an etchant, and forming a proanthocyanidin after etching ZIF-8 Hollow microcapsules for the wall material.
作为本发明的一个实施方案,在十六烷基三甲基溴化铵作为封端剂的水溶液中,控制六水硝酸锌2-甲基咪唑的反应时长,合成得到不同粒径大小的ZIF-8颗粒。As an embodiment of the present invention, in the aqueous solution of hexadecyltrimethylammonium bromide as end-capping agent, the reaction duration of zinc nitrate hexahydrate 2-methylimidazole is controlled, and ZIF- 8 pellets.
作为本发明的一个实施方案,控制反应时长为20~120min,合成得到50-200纳米的ZIF-8颗粒As an embodiment of the present invention, the control reaction time length is 20~120min, and the ZIF-8 particle of 50-200 nanometers is synthesized
作为本发明的一个实施方案,所述合成包括如下步骤:As one embodiment of the present invention, described synthesis comprises the following steps:
S1.十六烷基三甲基溴化铵水溶液和2-甲基咪唑水溶液混合均匀形成溶液D;S1. Cetyltrimethylammonium bromide aqueous solution and 2-methylimidazole aqueous solution are mixed uniformly to form solution D;
S2.将硝酸锌水溶液和溶液D混合后搅拌均匀后,22-28℃条件下静置形成溶液E;离心、洗涤、干燥后得到所述ZIF-8颗粒。S2. After mixing the zinc nitrate aqueous solution and the solution D, stirring evenly, standing at 22-28° C. to form a solution E; centrifuging, washing and drying to obtain the ZIF-8 particles.
作为本发明的一个实施方案,所述十六烷基三甲基溴化铵水溶液的质量浓度为0.10%-0.25%,2-甲基咪唑水溶液的质量浓度为4.5%-10%;所述硝酸锌水溶液是由500mg-1000mg的六水硝酸锌溶于100ml水中配置而得。As an embodiment of the present invention, the mass concentration of the cetyltrimethylammonium bromide aqueous solution is 0.10%-0.25%, the mass concentration of the 2-methylimidazole aqueous solution is 4.5%-10%; the nitric acid The zinc aqueous solution is prepared by dissolving 500mg-1000mg of zinc nitrate hexahydrate in 100ml of water.
作为本发明的一个实施示例,所述十六烷基三甲基溴化铵水溶液的质量浓度为0.18%,2-甲基咪唑水溶液的质量浓度为4.5%-10%;所述硝酸锌水溶液是由700mg的六水硝酸锌溶于100ml水中配置而得。As an implementation example of the present invention, the mass concentration of the cetyltrimethylammonium bromide aqueous solution is 0.18%, and the mass concentration of the 2-methylimidazole aqueous solution is 4.5%-10%; the zinc nitrate aqueous solution is Prepared by dissolving 700mg of zinc nitrate hexahydrate in 100ml of water.
作为本发明的一个实施方案,硝酸锌水溶液、2-甲基咪唑水溶液和十六烷基三甲基溴化铵水溶液以1~1.5:1~1.5:0.04~0.75的体积比混合。作为一个实施示例,硝酸锌水溶液、2-甲基咪唑水溶液和十六烷基三甲基溴化铵水溶液以1:1:0.045的体积比混合。As an embodiment of the present invention, the zinc nitrate aqueous solution, the 2-methylimidazole aqueous solution and the cetyltrimethylammonium bromide aqueous solution are mixed in a volume ratio of 1-1.5:1-1.5:0.04-0.75. As an implementation example, an aqueous solution of zinc nitrate, an aqueous solution of 2-methylimidazole, and an aqueous solution of cetyltrimethylammonium bromide are mixed at a volume ratio of 1:1:0.045.
作为本发明的一个实施方案,步骤S2中,静置时间为20~120min。其中,静置20~30min合成的ZIF-8颗粒平均粒径为50纳米;静置50±10min合成的ZIF-8颗粒平均粒径为100纳米;静置110±10min合成的ZIF-8颗粒平均粒径为200纳米。As an embodiment of the present invention, in step S2, the standing time is 20-120 minutes. Among them, the average particle diameter of ZIF-8 particles synthesized by standing for 20~30min is 50 nanometers; the average particle diameter of ZIF-8 particles synthesized by standing for 50±10min is 100 nm; The particle size is 200 nm.
作为本发明的一个实施方案,步骤S2中,所述离心、洗涤、干燥具体为:在9000-13000rpm条件下离心5-20分钟以收集沉淀并用无水甲醇洗涤2-5次并离心,最后将沉淀在45-60℃条件下真空干燥10-24小时。As an embodiment of the present invention, in step S2, the centrifugation, washing, and drying are specifically: centrifuging at 9000-13000rpm for 5-20 minutes to collect the precipitate and washing with anhydrous methanol for 2-5 times and centrifuging, and finally The precipitate was vacuum dried at 45-60°C for 10-24 hours.
作为本发明的一个实施示例,步骤S2中,所述离心、洗涤、干燥具体为:在10000rpm条件下离心10分钟以收集沉淀并用无水甲醇洗涤三次并离心,最后将沉淀在60℃条件下真空干燥12小时。As an implementation example of the present invention, in step S2, the centrifugation, washing, and drying are specifically: centrifuging at 10,000 rpm for 10 minutes to collect the precipitate, washing with anhydrous methanol three times and centrifuging, and finally vacuuming the precipitate at 60°C Let dry for 12 hours.
作为本发明的一个实施方案,原花青素刻蚀ZIF-8包括如下步骤:As an embodiment of the present invention, proanthocyanidin etching ZIF-8 comprises the following steps:
a.将ZIF-8颗粒均匀分散在去离子水中形成分散液A;a. Uniformly disperse ZIF-8 particles in deionized water to form dispersion A;
b.将原花青素均匀分散在去离子水中形成分散液B;b. uniformly dispersing the proanthocyanidins in deionized water to form dispersion B;
c.将所述分散液A和分散液B混合,在22-28℃下500-1000rpm搅拌0.5-12小时;混合液中分散液A的质量含量为1%-15%,分散液B的质量含量为85-99%;离心、洗涤、干燥后即得所述空心原花青素壁材微胶囊。c. Mix the dispersion A and dispersion B, and stir at 500-1000rpm at 22-28°C for 0.5-12 hours; the mass content of dispersion A in the mixed solution is 1%-15%, and the mass content of dispersion B is The content is 85-99%; the hollow proanthocyanidin wall material microcapsules can be obtained after centrifugation, washing and drying.
作为本发明的一个实施示例,ZIF-8颗粒平均粒径为50纳米时,步骤c中搅拌时间为30-40分钟;ZIF-8颗粒平均粒径为100纳米时,步骤c中搅拌时间为2-3小时;ZIF-8颗粒平均粒径为200纳米时,步骤c中搅拌时间为8-12小时。As an implementation example of the present invention, when the ZIF-8 particle average particle diameter is 50 nanometers, the stirring time is 30-40 minutes in the step c; when the ZIF-8 particle average particle diameter is 100 nanometers, the stirring time is 2 in the step c -3 hours; when the average particle size of ZIF-8 particles is 200 nanometers, the stirring time in step c is 8-12 hours.
作为本发明的一个实施方案,所述分散液A中ZIF-8颗粒的质量浓度为4%-20%;所述分散液B中原花青素的质量浓度为1%-10%。As an embodiment of the present invention, the mass concentration of ZIF-8 particles in the dispersion A is 4%-20%; the mass concentration of proanthocyanidins in the dispersion B is 1%-10%.
作为本发明的一个实施示例,所述分散液A中ZIF-8颗粒(平均粒径为200nm)的质量浓度为5%-20%,所述分散液B中原花青素的质量浓度为1%-10%。As an implementation example of the present invention, the mass concentration of ZIF-8 particles (average particle diameter is 200nm) in the dispersion liquid A is 5%-20%, and the mass concentration of proanthocyanidins in the dispersion liquid B is 1%-10% %.
作为本发明的一个实施方案,步骤c中,ZIF-8颗粒平均粒径为200-300纳米;搅拌时间为8-12小时。As an embodiment of the present invention, in step c, the average particle diameter of ZIF-8 particles is 200-300 nanometers; the stirring time is 8-12 hours.
作为本发明的一个实施方案,步骤c中,所述离心、洗涤、干燥具体包括:在9000-13000rpm条件下离心5-20分钟以收集沉淀,并用去离子水洗涤2-5次再次离心,最后将沉淀在45-60℃条件下真空干燥10-20小时。As an embodiment of the present invention, in step c, the centrifugation, washing, and drying specifically include: centrifuging at 9000-13000rpm for 5-20 minutes to collect the precipitate, washing with deionized water for 2-5 times and centrifuging again, and finally Dry the precipitate under vacuum at 45-60° C. for 10-20 hours.
作为本发明的一个实施示例,所述离心、洗涤、干燥具体包括:在10000rpm条件下离心10分钟以收集沉淀,并用去离子水洗涤3次再次离心,最后将沉淀在45℃条件下真空干燥12小时。As an implementation example of the present invention, the centrifugation, washing, and drying specifically include: centrifuging at 10,000 rpm for 10 minutes to collect the precipitate, washing with deionized water three times and centrifuging again, and finally vacuum drying the precipitate at 45°C for 12 Hour.
第二方面,本发明涉及一种上述制备方法制得的空心原花青素壁材微胶囊。In the second aspect, the present invention relates to a hollow proanthocyanidin wall material microcapsule prepared by the above preparation method.
第三方面,本发明涉及一种上述空心原花青素壁材微胶囊在药物包埋或精油包埋中的应用。In a third aspect, the present invention relates to an application of the above-mentioned hollow proanthocyanidin wall material microcapsules in drug embedding or essential oil embedding.
本发明旨在用较低成本获得空心原花青素壁材微胶囊,因而上述原花青素并非纯度特别高的原花青素单体,而是原花青素低聚物或多聚物。因纯度过高的原花青素价格较贵,限制了其被应用的场景。The present invention aims to obtain hollow proanthocyanidin wall material microcapsules at relatively low cost, so the above-mentioned proanthocyanidin is not a particularly high-purity proanthocyanidin monomer, but a proanthocyanidin oligomer or polymer. Proanthocyanidins with high purity are more expensive, which limits their application scenarios.
与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
1)本发明以安全简便的方法制备的ZIF-8作为牺牲模板,以原花青素作为刻蚀剂对ZIF-8进行刻蚀;1) The present invention uses ZIF-8 prepared by a safe and easy method as a sacrificial template, and uses proanthocyanidins as an etchant to etch ZIF-8;
2)在水溶液体系中因原花青素和ZIF-8的碰撞吸附,使得二者在水溶液中结合;而原花青素在水溶液中解离的H+充分解离ZIF-8,充分反应并洗涤后,仅留空心原花青素微胶囊存在于体系中;2) In the aqueous solution system, due to the collision adsorption of proanthocyanidins and ZIF-8, the two are combined in the aqueous solution; and the H + dissociated from the proanthocyanidins in the aqueous solution fully dissociates ZIF-8, and after fully reacting and washing, only the hollow Proanthocyanidin microcapsules exist in the system;
3)因原花青素本身具有优异的抗菌抗氧化性质,一方面空心原花青素壁材微胶囊包埋芯材后能够在一定程度上缓解芯材的释放;另一方面原花青素能够防止芯材与外界接触而产生的氧化变质;因而在药物包埋或精油包埋领域有较好的前景。3) Because proanthocyanidins themselves have excellent antibacterial and antioxidant properties, on the one hand, hollow proanthocyanidin wall material microcapsules can alleviate the release of core material to a certain extent; Oxidative deterioration; therefore, it has a good prospect in the field of drug embedding or essential oil embedding.
附图说明Description of drawings
通过阅读参照以下附图对非限制性实施例所作的详细描述,本发明的其它特征、目的和优点将会变得更明显:Other characteristics, objects and advantages of the present invention will become more apparent by reading the detailed description of non-limiting embodiments made with reference to the following drawings:
图1是实施例1中不同反应时间的ZIF-8纳米颗粒的扫描电镜图;Fig. 1 is the scanning electron micrograph of the ZIF-8 nanoparticles of different reaction times in embodiment 1;
图2是实施例2中实验四中空原花青素壁材的透射电镜图;Fig. 2 is the transmission electron microscope figure of experiment four hollow proanthocyanidin wall materials in embodiment 2;
图3是实施例2中实验五中空原花青素壁材的透射电镜图;Fig. 3 is the transmission electron microscope figure of experiment five hollow proanthocyanidin wall materials in embodiment 2;
图4是实施例2中实验六中空原花青素壁材的透射电镜图;Fig. 4 is the transmission electron microscope figure of experimental six hollow proanthocyanidin wall materials in embodiment 2;
图5是实施例2中实验七中空原花青素壁材的透射电镜图;Fig. 5 is the transmission electron micrograph of experiment seven hollow proanthocyanidin wall materials in embodiment 2;
图6是实施例2中中空原花青素壁材的透射电镜图;Fig. 6 is the transmission electron microscope picture of hollow proanthocyanidin wall material in embodiment 2;
图7是实施例3中柏木精油微胶囊的热重分析图。Fig. 7 is the thermal gravimetric analysis diagram of cedarwood essential oil microcapsules in embodiment 3.
具体实施方式Detailed ways
下面结合实施例对本发明进行详细说明。以下实施例将有助于本领域的技术人员进一步理解本发明,但不以任何形式限制本发明。应当指出的是,对本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干调整和改进。这些都属于本发明的保护范围。The present invention will be described in detail below in conjunction with examples. The following examples will help those skilled in the art to further understand the present invention, but do not limit the present invention in any form. It should be noted that those skilled in the art can make some adjustments and improvements without departing from the concept of the present invention. These all belong to the protection scope of the present invention.
原花青素是一种具有良好抗菌、抗氧化以及抗癌细胞活性的植物多酚类化合物。原花青素广泛存在于颜色较深的水果植物树皮当中。但原花青素没有固定的空间立体形态且易溶于极性溶剂中,因而普通的原花青素在包埋应用中受到限制。本发明的空心原花青素微胶囊是由ZIF-8作为牺牲模板,并以原花青素作为刻蚀剂对ZIF-8进行刻蚀,最终获得了粒径在200纳米左右的空心原花青素壁材微胶囊。以空心原花青素壁材微胶囊对柏木精油进行包埋,最终获得了约26%装载量的柏木精油缓释微胶囊。本发明旨在构建一种以原花青素为壁材的空心微胶囊,可用于易氧化变质的药物或精油的包埋领域。具体示例见以下各实施例:Proanthocyanidin is a plant polyphenolic compound with good antibacterial, antioxidant and anticancer activities. Proanthocyanidins are widely found in the bark of darker fruit plants. However, proanthocyanidins have no fixed three-dimensional shape and are easily soluble in polar solvents, so ordinary proanthocyanidins are limited in embedding applications. The hollow proanthocyanidin microcapsules of the present invention use ZIF-8 as a sacrificial template, and use proanthocyanidin as an etchant to etch the ZIF-8, and finally obtain hollow proanthocyanidin wall material microcapsules with a particle size of about 200 nanometers. The cedarwood essential oil was embedded in the hollow proanthocyanidin wall material microcapsules, and finally the cedarwood essential oil slow-release microcapsules with a loading capacity of about 26% were obtained. The invention aims to construct a hollow microcapsule with proanthocyanidin as the wall material, which can be used in the field of embedding of oxidatively degenerated medicines or essential oils. See the following examples for specific examples:
实施例1Example 1
ZIF-8颗粒的制备具体实施例如下:The specific examples of the preparation of ZIF-8 particles are as follows:
1)将六水硝酸锌(Zn(NO3)2·6H2O)溶于100mL去离子水形成溶液A,1) Dissolve zinc nitrate hexahydrate (Zn(NO 3 ) 2 6H 2 O) in 100mL deionized water to form solution A,
2)将2-甲基咪唑(C4H6N2)溶于100mL去离子水形成溶液B;2) Dissolving 2-methylimidazole (C 4 H 6 N 2 ) in 100 mL deionized water to form solution B;
3)将十六烷基三甲基溴化铵溶于10mL去离子水形成溶液C;3) dissolving cetyltrimethylammonium bromide in 10mL deionized water to form solution C;
4)将上述溶液B与溶液C充分搅拌混合均匀;再与溶液A混合后搅拌均匀(10分钟)后室温下静置反应不同时长,在10000rpm条件下10分钟以收集沉淀并用无水甲醇洗涤三次并,最后将沉淀在6℃条件下真空干燥12小时以得到ZIF-8晶体;其中,溶液A、溶液B和溶液C按1:1:0.045的体积比混合。4) Fully stir and mix the above solution B and solution C; then mix with solution A and stir evenly (10 minutes), then let it stand at room temperature for different periods of time, collect the precipitate at 10000rpm for 10 minutes and wash it with anhydrous methanol three times And, finally, the precipitate was vacuum-dried at 6° C. for 12 hours to obtain ZIF-8 crystals; wherein, solution A, solution B and solution C were mixed at a volume ratio of 1:1:0.045.
各个实验参数及试验结果总结如下:The experimental parameters and test results are summarized as follows:
根据实验一~实验三,在本实验条件下,ZIF-8颗粒的粒径与晶体生长时间有密切关系。当反应时间为20分钟时,ZIF-8晶体颗粒的大小约为50纳米,也被称之为纳米晶;当反应时间为50分钟时,ZIF-8晶体颗粒粒径约为100纳米;当反应时间为120分钟时,ZIF-8晶体颗粒约为200纳米(如图1所示)。According to experiments 1 to 3, under the experimental conditions, the particle size of ZIF-8 particles is closely related to the crystal growth time. When the reaction time was 20 minutes, the size of the ZIF-8 crystal particles was about 50 nanometers, also known as nanocrystals; when the reaction time was 50 minutes, the ZIF-8 crystal particle size was about 100 nanometers; When the time is 120 minutes, the ZIF-8 crystal particles are about 200 nanometers (as shown in FIG. 1 ).
实施例2Example 2
以ZIF-8为硬模板,以原花青素为刻蚀剂对ZIF-8进行刻蚀,制备中空原花青素微胶囊的具体实施例如下:Using ZIF-8 as a hard template and using proanthocyanidins as an etchant to etch ZIF-8, the specific examples of preparing hollow proanthocyanidin microcapsules are as follows:
1)将0.05g ZIF-8颗粒在超声作用下10分钟均匀分散在1mL去离子水中形成浊液A;1) Uniformly disperse 0.05g of ZIF-8 particles in 1mL of deionized water under the action of ultrasound for 10 minutes to form turbid solution A;
2)将1g原花青素在超声作用下均匀分散至99mL去离子水中形成浊液B;2) Uniformly disperse 1 g of proanthocyanidins into 99 mL of deionized water under the action of ultrasound to form turbid liquid B;
3)将上述浊液A和浊液B迅速混合,并在室温25℃下800rpm条件下搅拌不同时长,通过离心洗涤干燥等步骤获得中空原花青素壁材微胶囊;所述离心洗涤干燥具体为:在10000rpm条件下离心10分钟以收集沉淀,并用去离子水洗涤3次并离心,最后将沉淀在45℃条件下真空干燥12小时。3) Mix the above-mentioned turbid solution A and turbid solution B rapidly, and stir at room temperature at 25° C. at 800 rpm for different periods of time, and obtain hollow proanthocyanidin wall material microcapsules by centrifugal washing and drying; the centrifugal washing and drying is specifically: The precipitate was collected by centrifugation at 10000 rpm for 10 minutes, washed three times with deionized water and centrifuged, and finally the precipitate was vacuum-dried at 45° C. for 12 hours.
各个实验参数及试验结果总结如下:The experimental parameters and test results are summarized as follows:
根据实验四~实验七,原花青素刻蚀ZIF-8是一个与样品浓度相关和时间相关的过程。当模板颗粒较小时,对刻蚀剂的浓度要求较低,刻蚀时间较短就可完成,如实验四(图2)及实验五(图3)的结果。当模板颗粒较大时,刻蚀剂浓度太低(实验七,图5)、刻蚀时间不够(实验六,图4)都会影响刻蚀结果,即刻蚀不彻底,从而得到核壳结构。最终,我们通过实验八,获得了粒径约200纳米的中空原花青素壁材微胶囊,其微胶囊壁厚度约为20-30纳米(如图6所示)。According to experiments 4 to 7, the etching of ZIF-8 by proanthocyanidins is a process related to sample concentration and time. When the template particles are small, the concentration of the etchant is required to be low, and the etching time can be completed in a short time, such as the results of Experiment 4 (FIG. 2) and Experiment 5 (FIG. 3). When the template particles are large, the etchant concentration is too low (Experiment 7, Figure 5) and the etching time is not enough (Experiment 6, Figure 4) will affect the etching result, that is, the etching is not complete, thus obtaining the core-shell structure. Finally, through
本发明还尝试以槲皮素等小分子多酚来进行刻蚀,然而其无法刻蚀ZIF-8。The present invention also attempts to etch with small molecule polyphenols such as quercetin, but it cannot etch ZIF-8.
实施例3Example 3
以空心原花青素为壁材,对柏木精油进行包埋,制备柏木精油微胶囊的具体实施例如下:The specific examples of preparing cedarwood essential oil microcapsules by using hollow proanthocyanidins as wall materials are as follows:
1)将柏木精油在超声作用下均匀分散至无水乙醇中形成溶液A;1) Uniformly disperse cedarwood essential oil into absolute ethanol under the action of ultrasound to form solution A;
2)将中空原花青素壁材微胶囊颗粒加入溶液A中并在室温25℃左右超声10分钟;2) Add the hollow proanthocyanidin wall material microcapsule particles into solution A and ultrasonicate for 10 minutes at a room temperature of about 25°C;
3)将上述混合液在600rpm条件下搅拌包埋3小时;3) Stir and embed the above mixed solution at 600rpm for 3 hours;
4)通过离心、无水乙醇冲洗后冷冻干燥24小时以获得柏木精油微胶囊。4) Cedarwood essential oil microcapsules were obtained by centrifugation, washing with absolute ethanol and freeze-drying for 24 hours.
各个实验参数及试验结果如下:The experimental parameters and test results are as follows:
根据实验九~实验十一,通过热重分析结果,空心原花青素包埋柏木精油的最佳比例时,原花青素与柏木精油质量比为1;1。获得的最大装载量如图7所示。热重图中可以看出,在0-100℃的质量损失来自于体系中残存的水分的挥发。250℃开始出现的损失为原花青素的转变。350℃左右出现的质量损失来自于ZIF-8的转变。而精油体系中原则上有一部分轻质的烯烃类化合物,它们的沸点有有一些是低于100℃,通过热重图得出的柏木精油装载量约为26%质量分数,由于低沸点烯烃的挥发,柏木精油的实际装载量应高于26%质量分数。According to the results of experiments 9 to 11, the mass ratio of proanthocyanidins to cypress essential oil is 1;1 when the optimum ratio of hollow proanthocyanidins to embed cypress essential oil is obtained through thermogravimetric analysis. The maximum loading obtained is shown in Fig. 7. It can be seen from the thermogravimetric diagram that the mass loss at 0-100°C comes from the volatilization of the remaining water in the system. The loss that begins to appear at 250°C is the transformation of proanthocyanidins. The mass loss around 350 °C comes from the transformation of ZIF-8. In principle, there are some light olefinic compounds in the essential oil system, and some of their boiling points are lower than 100°C. The loading of cypress essential oil obtained by thermogravimetric diagram is about 26% by weight, due to the low boiling point olefins Volatile, the actual loading of cypress essential oil should be higher than 26% mass fraction.
以空心原花青素作为微胶囊壁材包埋药物或者精油等具有良好的效用。由于原花青素本身的抑菌、抗氧化、抗肿瘤细胞生长等特性,使得其作为微胶囊壁材可以发挥多重功效,在抑制其芯材药物或者精油氧化变质的作用外,原花青素自身也能够起到与药物协同的治疗作用或与精油协同的抑菌作用。因而,以空心原花青素作为微胶囊壁材,在医药领域或精油包埋领域有广阔的前景。Using hollow proanthocyanidins as microcapsule wall material to embed drugs or essential oils has a good effect. Due to the antibacterial, anti-oxidation, anti-tumor cell growth and other characteristics of proanthocyanidins themselves, it can play multiple functions as a microcapsule wall material. Synergistic therapeutic effect of drugs or synergistic antibacterial effect with essential oils. Therefore, using hollow proanthocyanidins as the wall material of microcapsules has broad prospects in the field of medicine or essential oil embedding.
以上对本发明的具体实施例进行了描述。需要理解的是,本发明并不局限于上述特定实施方式,本领域技术人员可以在权利要求的范围内做出各种变形或修改,这并不影响本发明的实质内容。Specific embodiments of the present invention have been described above. It should be understood that the present invention is not limited to the specific embodiments described above, and those skilled in the art may make various changes or modifications within the scope of the claims, which do not affect the essence of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110352188.6A CN113083176B (en) | 2021-03-31 | 2021-03-31 | A kind of preparation method and application of hollow proanthocyanidin wall material microcapsules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110352188.6A CN113083176B (en) | 2021-03-31 | 2021-03-31 | A kind of preparation method and application of hollow proanthocyanidin wall material microcapsules |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113083176A CN113083176A (en) | 2021-07-09 |
CN113083176B true CN113083176B (en) | 2023-02-28 |
Family
ID=76672193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110352188.6A Active CN113083176B (en) | 2021-03-31 | 2021-03-31 | A kind of preparation method and application of hollow proanthocyanidin wall material microcapsules |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113083176B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114028353A (en) * | 2021-12-16 | 2022-02-11 | 东莞波顿香料有限公司 | Procyanidine eye-protecting tablet and preparation method thereof |
CN114601019A (en) * | 2022-03-30 | 2022-06-10 | 广州瑞铂茵健康科技有限公司 | Application of placenta water-soluble extract as wall material for preparing probiotic microcapsules |
CN115287123A (en) * | 2022-08-03 | 2022-11-04 | 上海应用技术大学 | A kind of stable hollow metal-phenolic network essence microcapsule and preparation method thereof |
CN117645749A (en) * | 2023-12-01 | 2024-03-05 | 中国热带农业科学院农产品加工研究所 | PH response controlled release antibacterial film and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780060A (en) * | 1994-02-02 | 1998-07-14 | Centre National De La Recherche Scientifique | Microcapsules with a wall of crosslinked plant polyphenols and compositions containing them |
CN102941044A (en) * | 2012-11-06 | 2013-02-27 | 山东省农业科学院农产品研究所 | Preparation method of strawberry polyphenol microcapsules |
CN106565964A (en) * | 2016-11-04 | 2017-04-19 | 石家庄学院 | Preparation method of metal polyphenol vesicle material with micrometer/nanometer multilayer composite structure |
-
2021
- 2021-03-31 CN CN202110352188.6A patent/CN113083176B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780060A (en) * | 1994-02-02 | 1998-07-14 | Centre National De La Recherche Scientifique | Microcapsules with a wall of crosslinked plant polyphenols and compositions containing them |
CN102941044A (en) * | 2012-11-06 | 2013-02-27 | 山东省农业科学院农产品研究所 | Preparation method of strawberry polyphenol microcapsules |
CN106565964A (en) * | 2016-11-04 | 2017-04-19 | 石家庄学院 | Preparation method of metal polyphenol vesicle material with micrometer/nanometer multilayer composite structure |
Non-Patent Citations (2)
Title |
---|
Hui Wang et al..《Controlled Fabrication of Functional Capsules Based on the Synergistic Interaction between Polyphenols and MOFs under Weak Basic Condition》.《ACS Applied Materials & Interfaces》.2017,第9卷(第16期),第14258-14264页. * |
Yichang Pan et al..《Tuning the crystal morphology and size of zeolitic imidazolate framework-8 in aqueous solution by surfactants》.《CrystEngComm》.2011,第13卷(第23期),第6937-6940页. * |
Also Published As
Publication number | Publication date |
---|---|
CN113083176A (en) | 2021-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113083176B (en) | A kind of preparation method and application of hollow proanthocyanidin wall material microcapsules | |
Yi et al. | Preparation of strong antioxidative, therapeutic nanoparticles based on amino acid-induced ultrafast assembly of tea polyphenols | |
CN112205628A (en) | A kind of complex condensate with double-embedding function and its preparation method and application | |
CN102924929A (en) | Nanoparticles for encapsulating polyphenol active substances and preparation method thereof | |
CN104887583B (en) | A kind of preparation method of cellulose base Polyphenols natural anti-oxidation compound | |
KR101990060B1 (en) | Method for preparation of resveratrol nano-capsue and the nano-capsule therefrom | |
Zhou et al. | Elaboration and characterization of ε-polylysine‑sodium alginate nanoparticles for sustained antimicrobial activity | |
Li et al. | Microfluidic spinning of fucoxanthin-loaded nanofibers for enhancing antioxidation and clarification of fruit juice | |
CN105902401A (en) | Method for preparing H-polymer or J-polymer astaxanthin polymer nano dispersion system and application | |
Alexandre et al. | Cross-linked coacervates of cashew gum and gelatin in the encapsulation of pequi oil | |
CN111514097B (en) | A kind of preparation method of pH-responsive nano-hydrogel of walnut shell polyphenols | |
Pertiwi et al. | Microencapsulation of Ruellia tuberosa L. Extracts using alginate: preparation, biological activities, and release | |
CN114271492B (en) | High-rutin powder raw material composition, rutin powder, preparation method and application thereof | |
Yoksan et al. | Fabrication, characterization and in vitro release of vitexin-loaded chitosan nanoparticles | |
CN103989746B (en) | A kind of broussoflavone nanometer formulation and preparation method thereof | |
CN110403919B (en) | A kind of preparation method of carmine sulforaphane nano-capsules | |
CN110101871B (en) | A kind of preparation method of embedded resveratrol | |
CN114392248A (en) | Preparation method of anthocyanin-loaded nanoparticles | |
KR102305549B1 (en) | Method for Manufacturing Calamansi Powder | |
CN116268401B (en) | Procyanidine microcapsule and preparation method thereof | |
CN118267372A (en) | Preparation method of beta-carotene wrapped by hollow mesoporous silica nanoparticle | |
CN117158585A (en) | Preparation method of dried nobiletin-loaded yeast microcapsule | |
CN114431466B (en) | Procyanidine microcapsule and preparation method thereof | |
CN113892644B (en) | Proanthocyanidin nanoparticles encapsulated by polyelectrolyte complexation and preparation method thereof | |
CN105661549A (en) | Preparation method and application of with vitamin B1 and vitamin B6 supported by ferulic acid/chitosan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |